Publications
Science (New York, N.Y.)Jun 2024 |
384
(
6703
),
eadl0370
DOI:
10.1126/science.adl0370

Mef2d potentiates type-2 immune responses and allergic lung inflammation

Szeto, Aydan C H; Clark, Paula A; Ferreira, Ana C F; Heycock, Morgan; Griffiths, Emma L; Jou, Eric; Mannion, Jonathan; Luan, Shi-Lu; Storrar, Sophie; Knolle, Martin D; Kozik, Patrycja; Jolin, Helen E; Fallon, Padraic G; McKenzie, Andrew N J
Product Used
Variant Libraries
Abstract
Innate lymphoid cells (ILCs) and adaptive T lymphocytes promote tissue homeostasis and protective immune responses. Their production depends on the transcription factor GATA3, which is further elevated specifically in ILC2s and T helper 2 cells to drive type-2 immunity during tissue repair, allergic disorders, and anti-helminth immunity. The control of this crucial up-regulation is poorly understood. Using CRISPR screens in ILCs we identified previously unappreciated myocyte-specific enhancer factor 2d (Mef2d)-mediated regulation of GATA3-dependent type-2 lymphocyte differentiation. Mef2d-deletion from ILC2s and/or T cells specifically protected against an allergen lung challenge. Mef2d repressed Regnase-1 endonuclease expression to enhance IL-33 receptor production and IL-33 signaling and acted downstream of calcium-mediated signaling to translocate NFAT1 to the nucleus to promote type-2 cytokine-mediated immunity.
Product Used
Variant Libraries

Related Publications